Clinical Trial Update: NIV-MISA-NRDS Trial: a Multicenter Study in China [NA]

View source ↗

Summary

The NIV-MISA-NRDS trial, a multicenter study in China evaluating minimal invasive surfactant administration in neonates with respiratory distress syndrome, has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Respiratory Distress Syndrome

Drugs mentioned

• Exogenous Surfactant (surfactant)

Snippet

Sponsor: Peking University Third Hospital | Conditions: Minimal Invasive Surfactant Administration in Two Different Non-invasive Ventilation Modes to NRDS Infants | NA | Status: TERMINATED